Literature DB >> 2890820

Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis.

R F Harvey1, P C Gordon, N Hadley, D E Long, T R Gill, R I Macpherson, B C Beats, A J Tottle.   

Abstract

Sleeping with the bed-head raised is commonly recommended as treatment for patients with troublesome oesophagitis, but its effect has not been objectively tested. Ranitidine therapy is useful in oesophagitis, but it does not often produce complete relief of symptoms. The effects of each of these treatments alone and in combination have been studied in 71 patients with severe (grade III) peptic oesophagitis. Each treatment improved both symptoms and endoscopic appearances significantly more than placebo did. However, the combination of the two treatments was much better than either alone; the reduction in pain score and the area of ulceration healed were about twice those with either treatment alone. Smoking more than five cigarettes per day or drinking more than 30 g alcohol per day significantly reduced the effectiveness of ranitidine therapy, but age, sex, body weight, or the presence of a hiatus hernia had no detectable effect.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2890820     DOI: 10.1016/s0140-6736(87)91332-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  22 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

2.  A review of reflux esophagitis around the world.

Authors:  Edwin J Zarling
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

Review 3.  Treatment of gastro-oesophageal reflux disease in adults.

Authors:  J P Galmiche; E Letessier; C Scarpignato
Journal:  BMJ       Date:  1998-06-06

Review 4.  Twenty year cough in a non-smoker.

Authors:  P Glasziou
Journal:  BMJ       Date:  1998-05-30

Review 5.  Lifestyle measures in the management of gastro-oesophageal reflux disease: clinical and pathophysiological considerations.

Authors:  J H-E Kang; J Y Kang
Journal:  Ther Adv Chronic Dis       Date:  2015-03       Impact factor: 5.091

Review 6.  Histamine-2-receptor antagonists in gastro-oesophageal reflux.

Authors:  D G Colin-Jones
Journal:  Gut       Date:  1989-10       Impact factor: 23.059

7.  Barrett's Esophagus.

Authors:  Shanmugarajah Rajendra; Prateek Sharma
Journal:  Curr Treat Options Gastroenterol       Date:  2014-06

8.  An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

Authors:  S J Veldhuyzen van Zanten; N Flook; N Chiba; D Armstrong; A Barkun; M Bradette; A Thomson; F Bursey; P Blackshaw; D Frail; P Sinclair
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

Review 9.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

10.  Gastroesophageal reflux disease: medical or surgical treatment?

Authors:  Theodore Liakakos; George Karamanolis; Paul Patapis; Evangelos P Misiakos
Journal:  Gastroenterol Res Pract       Date:  2009-12-31       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.